Drug intelligence / Profile preview

Epaderm Cream

Development stage: Unknown
Lead developer: Mölnlycke
Administration: Topical

Overview

Epaderm Cream is a 2-in-1 emollient and skin cleanser designed for the management of dry skin conditions, including eczema, psoriasis, and ichthyosis. Developed by Mölnlycke Health Care, the formulation consists of six ingredients, including liquid paraffin, yellow soft paraffin, and glycerine. It functions through a dual mechanism: the paraffin components create an occlusive barrier on the skin surface to prevent transepidermal water loss, while glycerine acts as a humectant to attract and retain moisture within the skin layers. The product is free from fragrances, colorings, and sodium lauryl sulfate (SLS), making it suitable for all ages, including infants. It is widely used in clinical practice and is listed on the NHS Drug Tariff in the United Kingdom.

Brand names: Epaderm Cream
Other names: Epaderm

Beyond the preview

Go deeper on Epaderm Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epaderm Cream.

Explore the full profile